|
|
||||||||
CLINICAL STUDY |
1 Department of Pathology, Research Institute GROW, Maastricht University, Maastricht, The Netherlands, 2 Department of Human Biology, Nutrition Research Institute Maastricht (NUTRIM), Maastricht University, The Netherlands, 3 School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria, Australia and 4 Department of Movement Sciences, NUTRIM, Maastricht University, The Netherlands
(Correspondence should be addressed to L J C van Loon; Email: L.vanLoon{at}HB.unimaas.nl)
Objective: It has been suggested that adiponectin regulates plasma free fatty acid (FFA) clearance by stimulating FFA uptake and/or oxidation in muscle. We aimed to determine changes in plasma adiponectin concentration and adiponectin receptor 1 and 2 mRNA expression in skeletal muscle during and after prolonged exercise under normal, fasting conditions (high FFA trial; HFA) and following pharmacological inhibition of adipose tissue lipolysis (low FFA trial; LFA). Furthermore, we aimed to detect and locate adiponectin in skeletal muscle tissue.
Methods: Ten subjects performed two exercise trials (120 min at 50% VO2max). Indirect calorimetry was used to determine total fat oxidation rate. Plasma samples were collected at rest, during exercise and during post-exercise recovery to determine adiponectin, FFA and glycerol concentrations. Muscle biopsies were taken to determine adiponectin protein and adiponectin receptor 1 and 2 mRNA expression and to localise intramyocellular adiponectin.
Results: Basal plasma adiponectin concentrations averaged 6.57±0.7 and 6.63±0.8 mg/l in the HFA and LFA trials respectively, and did not change significantly during or after exercise. In the LFA trial, plasma FFA concentrations and total fat oxidation rates were substantially reduced. However, plasma adiponectin and muscle adiponectin receptor 1 and 2 mRNA expression did not differ between trials. Immunohistochemical staining of muscle cross-sections showed the presence of adiponectin in the sarcolemma of individual muscle fibres and within the interfibrillar arterioles.
Conclusion: Plasma adiponectin concentrations and adiponectin receptor 1 and 2 mRNA expression in muscle are not acutely regulated by changes in adipose tissue lipolysis and/or plasma FFA concentrations. Adiponectin is abundantly expressed in muscle, and, for the first time, it has been shown to be present in/on the sarcolemma of individual muscle fibres.
This article has been cited by other articles:
![]() |
J. E. Caminos, R. Nogueiras, F. Gaytan, R. Pineda, C. R. Gonzalez, M. L. Barreiro, J. P. Castano, M. M. Malagon, L. Pinilla, J. Toppari, et al. Novel Expression and Direct Effects of Adiponectin in the Rat Testis Endocrinology, July 1, 2008; 149(7): 3390 - 3402. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Gabler and M. E. Spurlock Integrating the immune system with the regulation of growth and efficiency J Anim Sci, April 1, 2008; 86(14_suppl): E64 - E74. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hojbjerre, M. Rosenzweig, F. Dela, J. M Bruun, and B. Stallknecht Acute exercise increases adipose tissue interstitial adiponectin concentration in healthy overweight and lean subjects Eur. J. Endocrinol., November 1, 2007; 157(5): 613 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. O'Leary, A. E. Jorett, C. M. Marchetti, F. Gonzalez, S. A. Phillips, T. P. Ciaraldi, and J. P. Kirwan Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E421 - E427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Bullen Jr., S. Bluher, T. Kelesidis, and C. S. Mantzoros Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1079 - E1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Kraemer and V. D. Castracane Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin Experimental Biology and Medicine, February 1, 2007; 232(2): 184 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Shen, J. A. Charlesworth, J. J. Kelly, K. W. Loi, and P. W. Peake Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease Nephrol. Dial. Transplant., January 1, 2007; 22(1): 171 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rodriguez-Pacheco, A. J. Martinez-Fuentes, S. Tovar, L. Pinilla, M. Tena-Sempere, C. Dieguez, J. P. Castano, and M. M. Malagon Regulation of Pituitary Cell Function by Adiponectin Endocrinology, January 1, 2007; 148(1): 401 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, K. T. Iida, H. Sone, T. Yokoo, N. Yamada, and R. Ajisaka The effect of exercise training on adiponectin receptor expression in KKAy obese/diabetic mice. J. Endocrinol., June 1, 2006; 189(3): 643 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bluher, J. W. Bullen Jr., J. H. Lee, S. Kralisch, M. Fasshauer, N. Kloting, J. Niebauer, M. R. Schon, C. J. Williams, and C. S. Mantzoros Circulating Adiponectin and Expression of Adiponectin Receptors in Human Skeletal Muscle: Associations with Metabolic Parameters and Insulin Resistance and Regulation by Physical Training J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2310 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Jacobi, N. K. Gabler, K. M. Ajuwon, J. E. Davis, and M. E. Spurlock Adipocytes, myofibers, and cytokine biology: New horizons in the regulation of growth and body composition J Anim Sci, April 1, 2006; 84(13_suppl): E140 - E. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |